1 unknown. .
Follow Patrick Robinson: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19 Ivermectin - Covid19, COVID-19 Pneumonia | Unknown | Patrick Robinson | 1000 | 2022-05-01 | 2022-04-27 |
COVID-19 (1)
Acetaminophen (1) · Albuterol (1) · Antibodies, Monoclonal (1) · Ascorbic Acid (1) · Aspirin (1) · Budesonide (1) · Ibuprofen (1) · Infusions, Intravenous (1) · Ivermectin (1) · Melatonin (1) · Niacin (1) · Quercetin (1) · Vitamin D (1) · Zinc (1) · remdesivir (1)
United States (1)
PMID 32615072, PMID 33227231, PMID 33234158, PMID 33278625, PMID 33293006, PMID 33389725